Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Lurbinectedin in FET-Fusion Tumors (LIFFT)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05918640
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:06.345628+00:00
Published At
2026-03-31T00:00:00+00:00
Record Updated At
2026-03-31
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Ewing Sarcoma", "Desmoplastic Small Round Cell Tumor", "Pediatric Cancer", "Undifferentiated Sarcoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-31"
protocolSection.identificationModule.nctId
"NCT05918640"
protocolSection.identificationModule.officialTitle
"Lurbinectedin in FET-Fusion Tumors (LIFFT)"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Ewing Sarcoma (protocolSection.conditionsModule.conditions)
  • Desmoplastic Small Round Cell Tumor (protocolSection.conditionsModule.conditions)
  • Pediatric Cancer (protocolSection.conditionsModule.conditions)
  • Undifferentiated Sarcoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.